Search
Search Results
##search.searchResults.foundPlural##
-
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2656PDF: 1638HTML: 2376Table1: 198 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1587PDF: 806HTML: 222 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1349PDF: 587Suppl. Files: 357HTML: 160 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3769PDF: 1492HTML: 190 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2010PDF: 832HTML: 704 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3848PDF: 1694HTML: 11654Figures Haase: 214 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1921PDF: 732HTML: 2123Untitled: 226Untitled: 159Untitled: 178Untitled: 162Untitled: 172Untitled: 185Untitled: 193 -
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2302PDF: 1000HTML: 4936 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1372PDF: 1262HTML: 465 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1826PDF: 720HTML: 411 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3745PDF: 1638HTML: 83 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2786PDF: 912HTML: 236 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3361PDF: 588HTML: 675 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3278PDF: 1034HTML: 2055 -
PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.
2687PDF: 1252HTML: 11812 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2347PDF: 1668HTML: 289 -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7888PDF: 734HTML: 223 -
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
3219PDF: 986HTML: 3140flowcytometric result of peripheral blood sample: 187 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2264PDF: 833HTML: 1640Figure 1: 205Table 1: 222 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
2971PDF: 1606HTML: 240 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
901PDF: 504HTML: 211Suppl. Files: 334 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3423PDF: 1304HTML: 2234Fi.1 Gritti.Rambaldi: 212 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1320PDF: 949HTML: 93 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
997PDF: 1228HTML: 117 -
The diagnostic pitfalls of mucormycosis
976PDF: 734HTML: 257







